Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have
no recent searches
You currently have no recent searches
Koskinen, L. O. D.*; Olivecrona, M.†; Rodling‐Wahlström, M.¶; Naredi, S.¶
*Umeå University Hospital, Neurokirurgen, NUS, Department of Neurosurgery; †Departmet of Neurosurgery; ¶Department of Anaesthesiology and Intensive Care, UMEÅ, Sweden
Previous studies have shown a correlation between initial GCS and outcome after sTBI. This correlation has been used to prognosticate outcome assessed as GOS. The aim was to investigate the value of GCS in prognostication of outcome in sTBI.
Patients with sTBI admitted 2002‐2005. Inclusion criteria: GCS at intubation and sedation ≤ 8, age 15‐70yr, first recorded CPP ≥ 10mmHg, and arrival within 24 h. Exclusion criteria: pregnant/lactating woman, penetrating injury. Protocol guided treatment based on the Lund concept was used. Independent staff evaluated the GOS at 3 and 6 months. Contingency analysis was used for evaluation of overall effects and ROC curve analysis was employed to evaluate the value of GCS in the prognostication of the dicotomized GOS (unfavourable GOS 1‐3 and favourable GOS 4‐5) outcome at 3 and 6 months.
In all, 48 patients, mean age 35.5yr, were included, no patient were lost to follow‐up. Median GCS at intubation and sedation was 6 (3‐8). Contingency analysis revealed no overall effects between the initial GCS and GOS at 3 months (P = 0.533) and 6 months (P = 0.269). Using the 3 months dicotomized GOS and the GCS value with highest accuracy (GCS ≤ 4) ROC analysis showed a sensitivity of 52.2% and specificity of 80.0%. The positive predictive value was 70.6% and negative prognostic value 64.5%. Positive likelihood ratio was 2.61 and negative likelihood ratio 0.60. Similar results were found using the 6 months outcome. If mortality prognostication is the ultimate goal the corresponding values are 30.4%, 84%, 63.6%, 56.8%, 1.90% and 0.83%, respectively.
In patients treated with an ICP targeted therapy, the prognostic value of initial GCS is insufficient to securely prognosticate the outcome. Based on our findings no absolute treatment decisions can be based on this variable.
© 2008 European Society of Anaesthesiology
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at European Journal of Anaesthesiology (EJA).
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in for
days or until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection